CBE ID
3746
Endorsement Status
1.1 New or Maintenance
Previous Endorsement Cycle
Is Under Review
No
Next Maintenance Cycle
Spring 2028
1.3 Measure Description
This outcome measure tracks the rate of adult patients (aged 18 years and older) treated and released from the Emergency Department (ED) with either a non-specific, presumed benign symptom-only dizziness diagnosis or a specific inner ear/vestibular diagnosis (collectively referred to as “benign dizziness”) who were subsequently admitted to a hospital for a stroke within 30 days of their ED visit.
-
-
1.14 Numerator
The number of ED treat-and-release index visit discharges during the performance period that are followed within 30 days by an inpatient hospital admission to any hospital that ends in a primary discharge diagnosis of stroke.
-
1.15 Denominator
Patients treated and released from the ED with a primary discharge diagnosis code of “benign dizziness”.
-
Exclusions
Not applicable.
-
OLD 1.12 MAT output not attachedAttached
-
Most Recent Endorsement ActivityPatient Safety Spring 2023Initial Endorsement
-
StewardJohns Hopkins Armstrong Institute for Patient Safety and QualitySteward Organization POC Email
-
-
Risk AdjustmentRisk adjustment approachOffRisk adjustment approachOffConceptual model for risk adjustmentOffConceptual model for risk adjustmentOff
-
Effective March 27, 2023, the National Quality Forum (NQF) is no longer the consensus-based entity (CBE) funded through the Centers for Medicare & Medicaid Services (CMS) National Consensus Development and Strategic Planning for Health Care Quality Measurement Contract. Battelle has been selected to oversee the endorsement & maintenance (E&M) of clinical quality and cost/resource use measures. Since the Spring 2023 cycle launched at NQF, measures submitted to this E&M cycle continued along the prior E&M protocols that were in place at time of the Spring 2023 “Intent to Submit.” Battelle took over the E&M work for the Spring 2023 cycle when developers and/or stewards submitted their full measure information, which for CBE #3746, the most recent measure specifications can be found here: https://p4qm.org/sites/default/files/2023-06/3746_-_avoid_hospitalization_after_release_with_a_misdiagnosis-ed_stroke_dizziness_avoid_h.a.r.m.-ed_stroke_dizziness.zip
To close out this E&M cycle, Battelle published the Spring 2023 measures for pre-evaluation public commenting, convened the E&M standing committees for their measure evaluation meetings, launched the Spring 2023 post-comment period, convened the E&M committees for the post-comment meeting, convened the CSAC to render a final endorsement decision, and executed the appeals period.